Absorption, Distribution, and Excretion of DJ-927, a Novel Orally Effective Taxane, in Mice, Dogs, and Monkeys (Pharmacology)
スポンサーリンク
概要
- 論文の詳細を見る
DJ-927, currently undergoing Phase I clinical trial, is a new orally effective taxane with potent antitumor effects. The absorption, tissue distribution, and excretion of DJ-927 were investigated in mice, dogs, and monkeys after a single oral administration. After oral administration of [^<14>C] DJ-927, radioactivity was rapidly absorbed, with the C_<max> occurring within 1-2 h in all species. The blood and plasma radioactivity elimination was biphasic and species-dependent. Elimination half-life of plasma in dogs was much longer than those in monkeys or mice. In mice, radioactivity was rapidly distributed to all tissues except for the central nervous system, especially to adrenal glands, liver, pituitary glands, kidneys, lungs, and spleen. In all species, radioactivity was mainly excreted in feces. Following a single oral administration to mice, more than 80% of the radioactivity was excreted within 48 h ; in dogs and monkeys, 80% of the radioactivity was excreted within 168h. Urinary excretion was less than 7% of radioactive dose in all species. In vitro plasma protein binding of [^<14>C] DJ-927 in the mouse, dog, and monkey plasma ranged from 92-98%. These studies showed that, the novel oral taxane DJ-927 was rapidly absorbed in all three species when administered by the oral route. The long biological half-life and slow elimination of radioactivity were distinctive in particular, compared with commercial taxanes. DJ-927 (as parent compound and its metabolites) is widely distributed to tissues except the brain. These preclinical data are useful for the design of clinical trials of DJ-927 and also for their interpretation.
- 公益社団法人日本薬学会の論文
- 2004-03-01
著者
-
Atsumi R
Daiichi Pharmaceutical Co. Ltd. Tokyo Jpn
-
Atsumi Ryo
Drug Metabolism & Physicochemical Property Research Laboratory Daiichi Pharmaceutical Co. Ltd.
-
Atsumi Ryo
Drug Metabolism & Analytical Chemistry Research Center Developmental Research Laboratories Daiic
-
ONO Chiho
Drug Metabolism & Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co., Ltd.
-
TAKAO Atsushi
Daiichi Pure Chemicals Co., Ltd.
-
Ono Chiho
Drug Metabolism & Physicochemical Property Research Laboratory Daiichi Pharmaceutical Co. Ltd.
-
Takao Atsushi
Daiichi Pure Chemicals Co. Ltd.
関連論文
- Deconvolution Analysis of the Regeneration Process of Mitomycin C from Prodrug in a Muscle Perfusion System Based on Statistical Moment Theory(Pharmaceutical,Chemical)
- Metabolic Activation of CPT-11,7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin, a Novel Antitumor Agent, by Carboxylesterase
- Pharmacokinetics of SN-38 [(+)-(4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano [3', 4' : 6,7]-indolizino [1,2-b] quinoline-3,14 (4H, 12H)-dione], an Active Metabolite of Irinotecan, after a Single Intravenous Dosing of ^C-SN-38 to Rats
- Metabolism of Irinotecan to SN-38 in a Tissue-Isolated Tumor Model
- Synthesis and Antitumor Activity of Novel Pyrimidinyl Pyrazole Derivatives. II. Optimization of the Phenylpiperazine Moiety of 1- [5-Methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3-phenylpiperazinyl-1-trans-propenes
- Synthesis and Antitumor Activity of Novel Pyrimidinyl Pyrazole Derivatives. III. Synthesis and Antitumor Activity of 3-Phenylpiperazinyl-1-trans-propenes
- Metabolic Fate of Clonidine (IV): Plasma Protein Binding of Clonidine In vitro and In vivo and Transfer to Fetus and Milk in Rats after Subcutaneous Administration of Clonidine
- Metabolic Fate of Clonidine (III): Absorption, Distribution and Excretion in Rats after Repeated Subcutaneous Administration of Clonidine
- Metabolic Fate of Clonidine (II): Absorption, Distribution and Excretion in Rats and Dogs after Dermal Application of Clonidine Tape, M-5041T
- Metabolic Fate of Clonidine (I): Absorption, Distribution and Excretion in Rats, Dogs and Monkeys after Subcutaneous Administration of Clonidine
- Absorption, Distribution, and Excretion of DJ-927, a Novel Orally Effective Taxane, in Mice, Dogs, and Monkeys (Pharmacology)
- Validation study of a method for assaying DE-310, a macromolecular carrier conjugate containing an anti-tumor camptothecin derivative, and the free drug in human plasma by HPLC and LC/MS/MS